ARTIBANI, Walter
 Distribuzione geografica
Continente #
NA - Nord America 13.366
EU - Europa 12.709
AS - Asia 9.404
SA - Sud America 1.179
AF - Africa 152
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 10
Totale 36.857
Nazione #
US - Stati Uniti d'America 13.100
RU - Federazione Russa 5.450
SG - Singapore 3.791
CN - Cina 3.383
GB - Regno Unito 2.218
BR - Brasile 963
SE - Svezia 925
HK - Hong Kong 839
FR - Francia 822
IT - Italia 724
IE - Irlanda 716
DE - Germania 703
FI - Finlandia 559
VN - Vietnam 557
UA - Ucraina 175
KR - Corea 173
CA - Canada 150
JP - Giappone 120
AR - Argentina 93
IN - India 92
TR - Turchia 91
MX - Messico 70
ID - Indonesia 67
NL - Olanda 65
ES - Italia 60
PL - Polonia 60
BD - Bangladesh 53
BE - Belgio 53
ZA - Sudafrica 53
AU - Australia 34
AT - Austria 31
LT - Lituania 26
MA - Marocco 26
EC - Ecuador 25
IQ - Iraq 24
AE - Emirati Arabi Uniti 23
CO - Colombia 21
VE - Venezuela 21
IL - Israele 20
PK - Pakistan 20
EG - Egitto 18
PY - Paraguay 18
CH - Svizzera 16
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
PE - Perù 14
KE - Kenya 13
LV - Lettonia 12
UZ - Uzbekistan 12
AZ - Azerbaigian 11
BG - Bulgaria 11
CL - Cile 11
KG - Kirghizistan 9
EU - Europa 8
IR - Iran 8
JO - Giordania 8
LB - Libano 8
PA - Panama 8
PH - Filippine 8
TN - Tunisia 8
MY - Malesia 7
RS - Serbia 7
UY - Uruguay 7
AM - Armenia 6
DK - Danimarca 6
DZ - Algeria 6
HU - Ungheria 6
NP - Nepal 6
PT - Portogallo 6
BO - Bolivia 5
GR - Grecia 5
GT - Guatemala 5
HR - Croazia 5
KZ - Kazakistan 5
LK - Sri Lanka 5
OM - Oman 5
SV - El Salvador 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
CY - Cipro 4
HN - Honduras 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TG - Togo 4
BB - Barbados 3
BH - Bahrain 3
BJ - Benin 3
CI - Costa d'Avorio 3
CU - Cuba 3
IS - Islanda 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
Totale 36.807
Città #
Singapore 1.911
Southend 1.888
Moscow 1.673
Chandler 1.611
Jacksonville 1.093
Ashburn 1.075
Dallas 1.067
Woodbridge 1.004
Hong Kong 826
Ann Arbor 756
Dublin 715
Beijing 712
Houston 533
New York 398
The Dalles 392
Wilmington 315
Lawrence 305
Princeton 305
Los Angeles 298
Jinan 264
Dearborn 222
Nanjing 217
Verona 202
Ho Chi Minh City 174
Helsinki 169
Shenyang 166
Columbus 129
Tianjin 122
Hebei 120
Redondo Beach 119
São Paulo 113
Munich 109
Tokyo 108
Buffalo 100
Haikou 95
Sindelfingen 93
Hanoi 92
Milan 81
Zhengzhou 81
Changsha 80
Ningbo 78
Santa Clara 77
Guangzhou 74
Seattle 66
Fuzhou 65
Nanchang 65
Redwood City 63
Dong Ket 62
Hangzhou 62
Montreal 54
Jiaxing 53
Taiyuan 53
Falls Church 52
Redmond 52
Seoul 52
Council Bluffs 51
San Francisco 50
Denver 49
Warsaw 49
Brooklyn 48
Volga 47
Boardman 46
Brussels 46
Norwalk 45
Frankfurt am Main 44
Stockholm 44
Taizhou 43
Orem 41
Phoenix 41
Turku 41
Atlanta 40
Johannesburg 38
London 38
Toronto 37
San Jose 36
Chicago 35
Chennai 34
Jakarta 34
Kent 34
Manchester 34
Mexico City 33
Poplar 32
Saint Petersburg 32
Rome 31
Rio de Janeiro 30
Detroit 27
Boston 26
Fairfield 25
Ankara 23
Lanzhou 23
Nuremberg 23
Washington 23
Amsterdam 21
Belo Horizonte 20
Brasília 20
Shanghai 19
Da Nang 18
Haiphong 17
Hefei 17
Kunming 17
Totale 22.183
Nome #
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 217
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 210
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 207
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 203
PD45-01 ASSOCIATION OF LOCAL ANAESTHETIC WOUNDS INFILTRATION AND ULTRASOUND TRANSVERSUS ABDOMINAL PLANE (US-TAP) BLOCK IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL 203
A new training model for robot-assisted urethrovesical anastomosis and posterior muscle-fascial reconstruction: the Verona training technique 201
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 199
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 199
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder 195
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 191
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 191
Argus-T Sling in 182 Male Patients: Short-term Results of a Multicenter Study 190
90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series 189
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 188
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 187
Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups. 185
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 185
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 183
Adenocarcinoma of the paraurethral glands: a case report 181
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 181
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 179
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 179
Association between postoperative thromboembolism prophylaxis and complications following urological surgery 178
Liver Metastases From Renal Oncocytoma With Vascular Extension 178
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 176
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 176
An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity 175
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 174
Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study 174
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 174
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 174
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 173
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 172
Bone density and skeletal metabolism in patients with orthotopic ileal neobladder. 171
MP5-16 QUALITY OF LIFE OF 171 PATIENTS WITH BLADDER CANCER UNDERGOING ILEAL ORTHOTOPIC NEOBLADDER: A MULTICENTRE STUDY AMONG LONG-TERM SURVIVORS 171
A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. 170
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 170
A PILOT RANDOMIZED TRIAL OF PREOPERATIVE PELVIC FLOOR MUSCLE EXERCISE VS USUAL CARE TO IMPROVE SEXUAL FUNCTION AND HEALTH RELATED QUALITY OF LIVE AFTER RARP: PRELIMINARY DISAPPOINTED RESULTS 168
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 166
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 165
Acute Ischemia of the Glans Penis after Circumcision Treated with Hyperbaric Therapy and Pentoxifylline: Case Report and Revision of the Literature 165
Impact of anatomical pielocaliceal topography in the treatment of renal lower calyces stones with extracorporeal shock wave lithotripsy. 164
A case of eosinophilic cystitis in patients with abdominal pain, dysuria, genital skin hyperemia and slight toxocariasis. 163
Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies 162
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 162
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 162
Impact of Combination of Local Anesthetic Wounds Infiltration and Ultrasound Transversus Abdominal Plane Block in Patients Undergoing Robot-Assisted Radical Prostatectomy: Perioperative Results of a Double-Blind Randomized Controlled Trial 162
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 161
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection 161
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 160
External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. 160
How radical prostatectomy procedures have changed over the last 10~years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 160
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-oncologico del Nord-est 159
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 159
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 159
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. 158
MP5-17 QUALITY OF LIFE IN SURVIVORS FROM RADICAL CYSTECTOMY. THE USE OF QUALITATIVE ANALYSIS 158
Endogenous testosterone as a predictor of prostate growing disorders in the aging male 158
Antegrade scrotal sclerotherapy in the treatment of varicocele: a prospective study. 157
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 157
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE (IPSS) AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 157
Mathematical models for prognostic prediction in patients with renal cell carcinoma. 156
Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery 156
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 155
High surgeon volume and positive surgical margins can predict the risk of biochemical recurrence after robot-assisted radical prostatectomy 154
Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate Cancer 153
Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study 153
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 153
HEALTH-RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY IN SURVIVED PATIENTS WITH AN ILEAL CONDUIT OR ILEAL ORTHOTOPIC NEOBLADDER DIVERSION: A COMPARATIVE PROPENSITY-SCORE MATCHED ANALYSIS 151
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 150
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 150
AR-V7 and prostate cancer: The watershed for treatment selection? 149
Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. 148
Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer 148
Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set 148
Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy 148
Long-term follow-up of anterior vaginal repair: A comparison among colporrhaphy, colporrhaphy with reinforcement by xenograft, and mesh 147
Advances in Female Urology: A Review of the 2013 Literature 145
43rd Annual Congress of the Italian Urodynamic Society, Rome, Italy, 13th-15th June 2019: Sacral neuromodulation in patients with lower urinary tract symptoms and affected by epilepsy: a multicentre study 144
Robotic bladder diverticulectomy: step-by-step extravesical posterior approach - technique and outcomes 144
A COMPARISON OF VOIDED VOLUMES BETWEEN VOIDING DIARIES AND UROFLOWMETRY 144
COMPRENSIONE AMBULATORIALE DEL QUESTIONARIO IIEF-5 143
PURE STRESS URINARY INCONTINENCE: ANALYSIS OF THE PREVALENCE, ESTIMATION OF COSTS AND FINANCIAL IMPACT. 143
Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires 143
Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection 143
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 143
Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion 143
Continence and complications rates after male slings as primary surgery for post-prostatectomy incontinence: a systematic review. 142
Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized Disease 142
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 142
Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy. 142
Late complications after intravaginal slingplasty for female stress urinary incontinence 140
COMPARISON OF THE LONG-TERM OUTCOMES OF MIDDLE URETHRAL SLING VERSUS MIDDLE URETHRAL SLING PLUS ANTERIOR VAGINAL REPAIR FOR CYSTOCELE - DOES ANTERIOR REPAIR INFLUENCE RESULTS ON CONTINENCE? 139
Modified antegrade scrotal sclerotherapy in adolescent patients with varicocele 138
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update 138
Use of AUC7 adjuvant carboplatin in patients with stage I seminoma: systematic review of the literature 138
IMPACT OF PREOPERATIVE PATIENTS' CHARACTERISTICS AND FLOW RATE ON FAILURE, EARLY COMPLICATIONS AND VOIDING DYSFUNCTION AFTER TRANSOBTURATORY TAPE PROCEDURE: A RETROSPECTIVE MULTI-CENTRE STUDY 138
Prostate specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low risk prostate cancer 138
Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomy 138
Pain assessment after original transperineal prostate biopsy using a coaxial needle. 137
Totale 16.378
Categoria #
all - tutte 132.407
article - articoli 122.809
book - libri 0
conference - conferenze 8.531
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.067
Totale 264.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021872 0 0 0 0 0 252 43 95 62 43 229 148
2021/20222.299 206 533 28 291 77 62 46 140 81 57 133 645
2022/20234.684 346 395 456 814 392 1.160 48 346 520 29 119 59
2023/20242.358 112 183 172 285 335 355 79 160 26 153 372 126
2024/20256.028 322 445 215 1.066 356 165 251 246 959 382 468 1.153
2025/202612.282 1.262 772 1.203 3.002 4.791 1.252 0 0 0 0 0 0
Totale 37.381